SCYNEXIS, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
SCYNEXIS, Inc. (SCYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 32.49 thousand shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2020-11-06
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-09-30 was 9.73K shares, a 97.45% decline year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-06-30 was -117.74K shares, a 255.91% decline year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-03-31 was 140.50K shares, a 987.87% increase year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-09-30 was 381.62K shares, a 956.73% increase year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 220.00 shares, a 99.62% decline from fiscal 2016.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 58.26K shares, a 49.65% decline from fiscal 2015.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2015 was 115.71K shares, a 170.61% increase from fiscal 2014.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2014 was 42.76K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2020-09-30 | 9.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -108.01K shares derived: sum of 2 quarters · filed 2020-11-06 | 32.49K shares 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -117.74K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 22.76K shares 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | 140.50K shares 10-Q · filed 2020-05-11 | |||
| 2019-09-30 | 381.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 457.14K shares derived: sum of 2 quarters · filed 2019-11-12 | 470.05K shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 75.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 88.44K shares 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | 12.91K shares 10-Q · filed 2019-05-08 | |||
| 2018-09-30 | 36.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 149.09K shares derived: sum of 2 quarters · filed 2018-11-13 | 183.82K shares 10-Q · filed 2018-11-13 | 183.82K shares derived: sum of 4 quarters · filed 2018-11-13 |
| 2018-06-30 | 112.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 147.71K shares 10-Q · filed 2018-08-09 | 147.71K shares derived: sum of 3 quarters · filed 2018-08-09 | 147.85K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 34.73K shares 10-Q · filed 2018-05-08 | 34.73K shares derived: sum of 2 quarters · filed 2018-05-08 | 34.88K shares derived: sum of 3 quarters · filed 2018-05-08 | 34.88K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 147.00 shares derived: sum of 2 quarters · filed 2018-03-13 | 147.00 shares derived: sum of 3 quarters · filed 2018-03-13 | 220.00 shares 10-K · filed 2018-03-13 |
| 2017-09-30 | 147.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 147.00 shares derived: sum of 2 quarters · filed 2017-11-07 | 220.00 shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 73.00 shares 10-Q · filed 2017-08-08 | ||
| 2017-03-31 | 73.00 shares 10-Q · filed 2017-05-08 | |||
| 2016-12-31 | 58.26K shares 10-K · filed 2018-03-13 | |||
| 2015-12-31 | 115.71K shares 10-K · filed 2017-03-13 | |||
| 2014-12-31 | 42.76K shares 10-K · filed 2016-03-07 | |||
| 2013-12-31 | 27.97K shares 8-K · filed 2015-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |